Yourgene Health’s (YGEN) “Corporate” Rating Reaffirmed at FinnCap

FinnCap reiterated their corporate rating on shares of Yourgene Health (LON:YGEN) in a report released on Monday morning.

YGEN stock opened at GBX 13.25 ($0.17) on Monday.

About Yourgene Health



Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.

Featured Story: How Buying a Call Option Works

Receive News & Ratings for Yourgene Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yourgene Health and related companies with MarketBeat.com's FREE daily email newsletter.